Key result
HIF-1 alpha was investigated as a possible cardiac hypoxia marker in acute cardiac ischemia, but no results were reported in the abstract.
Why the study?
HIF-1 alpha activity increases in tissue ischemia to regulate cellular oxygen and promote vascular remodeling, but its role as a cardiac hypoxia marker and relationship with inflammatory and biochemical parameters in acute cardiac ischemia needed investigation.
Can HIF-1 alpha serve as a cardiac hypoxia marker in acute coronary ischemia?
Observational
Can HIF-1 alpha serve as a cardiac hypoxia marker in acute coronary ischemia?
This study aims to evaluate the utility of HIF-1 alpha as a novel biomarker for cardiac hypoxia in the setting of acute coronary ischemia.
HIF-1α evaluation in acute coronary ischemia remains hypothesis-generating; prospective validation required before clinical adoption.
Objective: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a gene protein whose activation is a primary defensive mechanism against tissue hypoxia. It is the main regulator of cellular oxygen delivery and consumption. HIF-1 alpha activity is increased in tissue ischemia and this induces the angiogenic growth factor release that is needed for vascular remodeling and collateral formation, and contributes to improvement in cardiac functions. In this study, it was aimed to measure HIF-1 alpha levels in acute cardiac ischemia, to evaluate its relationship with inflammatory and biochemical parameters, and to investigate HIF-1 alpha as a possible cardiac hypoxia marker.
No takes yet. Share an insight, caveat, or question.
Akbaş et al. (2021) conducted an observational in Acute cardiac ischemia. HIF-1 alpha was evaluated on HIF-1 alpha levels and relationship with inflammatory and biochemical parameters. HIF-1 alpha was investigated as a possible cardiac hypoxia marker in acute cardiac ischemia, but no results were reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: